Lixisenatide In the ELIXA (Evaluation of Lixisenatide in Acute Coronary Syndrome) study, T2D patients with a recent coronary artery event were randomly assigned (1:1) to a lixisenatide (1020 g) group or placebo group (Pfeffer et al., 2015)
It is a partial sequence of a body protection compound discovered in and isolated from human gastric juice
If your job is journalist, you would serve your readers and viewers better by pointing out the absolute risk reduction, and making sure you dont echo any mismatched framing
10.1111/ppe.12181 53 Factor-LitvakP.SusserE.KeziosK.McKeagueI.KarkJ
Skadniki L-Karnityna Xplode Powder skadniki L-winian L-karnityny 74,7%, aromaty, maltodekstryna, tlenek magnezu, substancja przeciwzbrylajca: dwutlenek krzemu
NNMT also lowers NAD+, affecting how our bodies use energy and handle fat